Generic Name: Recombinant Human Erythropoietin (EPO)

Therapeutic Segment: Erythropoiesis-stimulating Agent

Indications:

-Treatment of Anemia in Chronic Kidney Failure /ESKD patients

-Treatment of Chemotherapy induced Anemia in Cancer patients

-Treatment of Anemia in Zidovudine-treated HIV-infected patients

-Reduction of Allogeneic Red Blood Cell transfusions in patients
  undergoing Elective, Noncardiac, Nonvascular surgery.

Strengths: 2000 IU, 4000 IU PFS & 10,000 IU vial

Pack Size: 1’s